SCHEMBL1508356

SCHEMBL1508356

Cc1ccc2cc(NC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)[C@H](CC(C)C)N3C(=O)CCC3=O)c(=O)oc2c1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MET P08581 1/20 0.40
▸ ACE P12821 3/20 0.38
▸ KDR P35968 1/20 0.37
▸ FOLH1 Q04609 1/20 0.37
▸ ADAM17 P78536 2/20 0.36
▸ MAOB P27338 1/20 0.35
▸ OPRD1 P41143 1/20 0.35
▸ MMP2 P08253 2/20 0.35
▸ NPY4R P50391 2/20 0.35
▸ NPY1R P25929 1/20 0.35
▸ NPY2R P49146 1/20 0.35
▸ NPY5R Q15761 1/20 0.35
▸ MMP9 P14780 1/20 0.35
▸ MMP8 P22894 1/20 0.35
▸ TP53 P04637 2/20 0.35
▸ AKR1B10 O60218 1/20 0.35
▸ AKR1B1 P15121 1/20 0.35
▸ POLB P06746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7771849 0.78 KDR (0.36) METKDRFOLH1ADAM17MAOB
SCHEMBL1767417 0.76 TDP1 (0.44) POLB
SCHEMBL1193133 0.71 TDP1 (0.39) POLB
SCHEMBL6748044 0.70 KDR (0.44) ACEKDRFOLH1ADAM17MAOB
SCHEMBL9074200 0.66 ACE (0.56) ACEFOLH1
SCHEMBL6933429 0.64 KDM4E (0.68) MAOBTP53POLB
SCHEMBL11688646 0.62 ALDH1A1 (0.52) MMP2MMP9MMP8POLB
SCHEMBL5010177 0.61 ALDH1A1 (0.77) POLB
SCHEMBL112098 0.61 ALDH1A1 (0.77) POLB
SCHEMBL5287723 0.60 ADAM17 (0.81) ADAM17MAOBMMP2MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2289970-B1 Biocompatible polymers BARRITAULT DENIS (FR) 2015-05-20 — — EP disclosed
EP-1117695-B1 BIOCOMPATIBLE POLYMERS, COMPOSITIONS CONTAINING SAME AND THEIR USE FOR THE MANUFACTURE OF DRUGS BARRITAULT DENIS (FR) 2015-05-20 — — EP disclosed
US-8883715-B2 Biocompatible polymers, process for their preparation and compositions containing them BARRITAULT DENIS (FR) 2014-11-11 — — US disclosed
US-20130287725-A1 BIOCOMPATIBLE POLYMERS, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM BARRITAULT DENIS (FR) 2013-10-31 — — US disclosed
US-8476220-B2 Biocompatible polymers, process for their preparation and compositions containing them BARRITAULT DENIS (FR) 2013-07-02 — — US disclosed
US-20110243881-A1 BIOCOMPATIBLE POLYMERS, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM BARRITAULT DENIS 2011-10-06 — — US disclosed
US-7998922-B2 Process for treating fibroses with biocompatible polymer BARRITAULT DENIS 2011-08-16 — — US disclosed
EP-2289970-A1 Biocompatible polymers, their process of manufacture and compositions containing them Barritault, Denis (FR) 2011-03-02 — — EP disclosed
US-20090012040-A1 BIOCOMPATIBLE POLYMERS, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM BARRITAULT DENIS 2009-01-08 — — US disclosed
US-20040131583-A1 Therapy, medical diagnosis; cardiovascular disorders, central nervous system disorders, liver disorders, brain disorders; oxidation resistance BARRITAULT DENIS (FR) 2004-07-08 — — US disclosed
US-6689741-B2 DRUGS, MEDICAL DIAGNOSIS BARRITAULT DENIS (FR) 2004-02-10 — — US disclosed
US-20010021758-A1 Drugs, medical diagnosis BARRITAULT DENIS (FR) 2001-09-13 — — US disclosed
Send feedback